Clients trust Jake to anticipate the unknown and structure complex agreements that protect their interests over the long term.
Jake counsels life sciences and technology clients—ranging from emerging growth companies to established tech businesses—at formation through exit. Leveraging a background in molecular biology, Jake is recognized for his innovative, forward-thinking approach to helping early-stage biotechnology companies maximize the value of company assets.
In a deal praised by news media as a “pivotal event,” Jake represented Calico, the Google-backed life sciences company, in a novel scientific collaboration with AbbVie, a global, research-based biopharmaceutical company, to research and develop therapeutics for age-related diseases. On the technology side, Jake counseled 26 member-investor companies—collectively known as Allied Security Trust—in a unique collaboration to acquire all 498 patents from MIPS Technologies.
Whether he is bringing in core IP from a university or facilitating a company’s first collaboration with a pharmaceutical company, clients trust Jake to anticipate the unknown and structure complex agreements that protect their interests over the long term.
Jake is an “experienced, extremely business-savvy and efficient lawyer who represents great value.”
IAM Strategy 300
2017 Edition
Recognition Recognition Recognition
Recognition Recognition Recognition
2024
Recognized for Healthcare: Life Sciences and as a Leading Lawyer for Media, Technology and Telecoms: Technology Transactions
2023
Recognized Jake as a Transactions Star
2024
Consistently honors Jake as one of the top transactions practitioners in California, most recently in 2024. Jake was also named to the IAM Global Leaders list (2024-2025).
2024
Recognized Jake as one of the world’s leading IP strategists for patent transactions.